Literature DB >> 2882537

Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon.

R J Lamb, R R Griffiths.   

Abstract

MDMA (d,1-3,4-Methylenedioxymethamphetamine HCl; "ecstasy") self-injection (0.1-3.2 mg/kg/injection) was examined in baboons under conditions in which baseline responding was maintained by intravenous injections of cocaine HCl (0.32 mg/kg/injection). Drug was available under a FR 160-response schedule of intravenous injection. Each drug injection was followed by a 3-h time out allowing a maximum of eight injections per day. MDMA or MDMA vehicle (saline) was substituted for cocaine for a period of 14 or more days followed by a return to the cocaine baseline. MDMA (0.32-3.2 mg/kg/inj) maintained more injections and higher responses rates than were maintained by saline. The maximal number of injections maintained by MDMA and the maximal response rate maintained by MDMA were less than those maintained under baseline conditions with cocaine. The highest dose of MDMA tested maintained a cyclic pattern of self-injection, i.e., days of high numbers of injections intermixed with days of low numbers of injections. At the highest dose of MDMA tested, concurrent food maintained behavior was suppressed to an extent that food intake was also decreased.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882537     DOI: 10.1007/bf00518175

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Addiction to secobarbital and chlordiazepoxide in the rhesus monkey by means of a self-infusion preference procedure.

Authors:  J D Findley; W W Robinson; L Peregrino
Journal:  Psychopharmacologia       Date:  1972

Review 2.  Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents.

Authors:  R A Glennon; J A Rosecrans; R Young
Journal:  Med Res Rev       Date:  1983 Jul-Sep       Impact factor: 12.944

3.  Stereoselective effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) on schedule-controlled behavior.

Authors:  R A Harris; D Snell; H H Loh
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

4.  Discriminative stimulus properties of MDA analogs.

Authors:  R A Glennon; R Young; J A Rosecrans; G M Anderson
Journal:  Biol Psychiatry       Date:  1982-07       Impact factor: 13.382

5.  Comparison of behavior maintained by infusions of eight phenylethylamines in baboons.

Authors:  R R Griffiths; G Winger; J V Brady; J D Snell
Journal:  Psychopharmacology (Berl)       Date:  1976-11-24       Impact factor: 4.530

6.  MDA: a psychoactive agent with dual stimulus effects.

Authors:  R A Glennon; R Young
Journal:  Life Sci       Date:  1984-01-23       Impact factor: 5.037

7.  Further investigation of the discriminative stimulus properties of MDA.

Authors:  R A Glennon; R Young
Journal:  Pharmacol Biochem Behav       Date:  1984-04       Impact factor: 3.533

8.  Structure-activity studies on methoxy-substituted phenylisopropylamines using drug discrimination methodology.

Authors:  R A Glennon; R Young; A E Hauck
Journal:  Pharmacol Biochem Behav       Date:  1985-05       Impact factor: 3.533

9.  A tethering system for intravenous and intragastric drug administration in the baboon.

Authors:  S E Lukas; R R Griffiths; L D Bradford; J V Brady; L Daley
Journal:  Pharmacol Biochem Behav       Date:  1982-10       Impact factor: 3.533

10.  Effects of d-amphetamine, monomethoxyamphetamines and hallucinogens on schedule-controlled behavior.

Authors:  R A Harris; D Snell; H H Loh
Journal:  J Pharmacol Exp Ther       Date:  1978-01       Impact factor: 4.030

View more
  24 in total

1.  Role of the endocannabinoid system in MDMA intracerebral self-administration in rats.

Authors:  Daniela Braida; Mariaelvina Sala
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

2.  Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.

Authors:  Melanie Mueller; Amy K Goodwin; Nancy A Ator; Una D McCann; George A Ricaurte
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

Review 3.  The behavioral pharmacology of hallucinogens.

Authors:  William E Fantegrossi; Kevin S Murnane; Chad J Reissig
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

4.  A reliable model of intravenous MDMA self-administration in naïve mice.

Authors:  José Manuel Trigo; Fany Panayi; Guadalupe Soria; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

5.  Blasted with ennui.

Authors:  G Edwards
Journal:  BMJ       Date:  1989-01-21

6.  MDMA produces stimulant-like conditioned locomotor activity.

Authors:  L H Gold; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

Authors:  L H Gold; C B Hubner; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.

Authors:  Kevin T Ball; George V Rebec
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

9.  Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine.

Authors:  Zhixia Wang; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2006-10-25       Impact factor: 4.530

10.  Pharmacological profile of novel psychoactive benzofurans.

Authors:  Anna Rickli; Simone Kopf; Marius C Hoener; Matthias E Liechti
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.